
Gliknik
Operator of a biopharmaceutical company intended to treat cancer and autoimmune diseases. The company offers a drug module for the immune system to fight disease and ease human suffering by creating n...
Valuation
$0
Share Price
N/A
Total Raised
$124.8M
Last Round
N/A